Partner
Pillsbury Winthrop Shaw Pittman LLP
Columns
| Title | Category | Published |
|---|---|---|
| Mifepristone debate could jeopardize access to many other FDA-approved drugs | Health Care & Hospital Law, Government | May 12, 2023 |
| What's the right remedy for a constitutional structural wrong? | U.S. Supreme Court, Government, Constitutional Law, Administrative/Regulatory | Dec. 21, 2020 |
| Tea leaves and the CFPB | U.S. Supreme Court, Government, Constitutional Law | Jul. 13, 2020 |
| CFPB survives, but for how long? | U.S. Supreme Court, Government, Constitutional Law, Administrative/Regulatory | May 15, 2019 |
| Judge Brett Kavanaugh and the administrative state | U.S. Supreme Court, Constitutional Law, Administrative/Regulatory | Sep. 26, 2018 |
| Title | Category | Published |
|---|---|---|
| Mifepristone debate could jeopardize access to many other FDA-approved drugs | Health Care & Hospital Law, Government | May 12, 2023 |
| What's the right remedy for a constitutional structural wrong? | U.S. Supreme Court, Government, Constitutional Law, Administrative/Regulatory | Dec. 21, 2020 |
| Tea leaves and the CFPB | U.S. Supreme Court, Government, Constitutional Law | Jul. 13, 2020 |
| CFPB survives, but for how long? | U.S. Supreme Court, Government, Constitutional Law, Administrative/Regulatory | May 15, 2019 |
| Judge Brett Kavanaugh and the administrative state | U.S. Supreme Court, Constitutional Law, Administrative/Regulatory | Sep. 26, 2018 |